Continuation Protocol to Protocol BBCO-001
NCT02328482
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Muscular Dystrophy, Oculopharyngeal (OPMD)
Interventions
DRUG:
Tehalose 30gr
Sponsor
Bioblast Pharma Ltd.